Search results for "Acetonide"

showing 10 items of 30 documents

Novel inulin-based mucoadhesive micelles loaded with corticosteroids as potential transcorneal permeation enhancers

2017

In this work a new copolymer of inulin (INU) derivatized with ethylendiamine (EDA) and retinoic acid (RA), named INU-EDA-RA, was synthetized, characterized and employed to produce micelles as carriers for topical administration of corticosteroids for the potential treatment of diseases of posterior eye segment. Spectroscopic analysis confirmed a molar derivatization degree of 11.30 and 4.30% in EDA and RA, respectively. INU-EDA-RA micelles are capable of strong mucoadhesive interactions which result time-independent and stable over time but concentration depending. Moreover micelles are able to encapsulate efficiently from 3 to 13% (w/w) of lipophilic drugs, as dexamethasone, triamcinolone …

DrugTriamcinolone acetonideTranscorneal enhancerCell SurvivalSwineAdministration Topicalmedia_common.quotation_subjectTranswellPharmaceutical ScienceMucoadhesionRetinal Pigment Epithelium02 engineering and technologyOcular disease030226 pharmacology & pharmacyMicellePermeabilityCorneaMice03 medical and health sciences0302 clinical medicineAdrenal Cortex HormonesPolymeric micelleRetinoic acidCell AdhesionMucoadhesionmedicineCorticosteroidAnimalsHumansDissolution testingOcular topical administrationMicellesmedia_commonDrug CarriersChromatographyDose-Response Relationship DrugChemistryInulinGeneral Medicine021001 nanoscience & nanotechnologyPermeability (electromagnetism)Cattle0210 nano-technologyDrug carrierDrug metabolismBiotechnologymedicine.drugEuropean Journal of Pharmaceutics and Biopharmaceutics
researchProduct

The use of topical corticosteroides in the treatment of oral lichen planus in Spain: A national survey

2017

Background Explore the treatment of oral lichen planus with topical corticosteroids by the healthcare professionals in Spain. Material and Methods A questionnaire targeted health professionals who treat OLP, in particular maxillofacial surgeons, dermatologist and dentist. The dissemination of the questionnaires was conducted through professional associations and dental and medical societies. The questionnaire was previously evaluated by means of a cognitive pre-test procedure to ensure that the questions were opportune and appropriate, understandable and acceptable among the professionals. Results Of the 890 questionnaires sent a total of 190 questionnaires were answered by 90 dentists, 60 …

medicine.medical_specialtyTriamcinolone acetonideAdministration TopicaleducationMEDLINEDentistry030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineCombined treatmentstomatognathic systemMedicineHumans030212 general & internal medicinePractice Patterns Physicians'skin and connective tissue diseasesGeneral DentistryGlucocorticoidsMaxillofacial surgeonsOral Medicine and Pathologyintegumentary systemHealth professionalsbusiness.industryResearch:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseDermatologystomatognathic diseasesOtorhinolaryngologyTopical corticosteroidSpainHealth Care SurveysUNESCO::CIENCIAS MÉDICASSurgeryOral lichen planusTreatment timeSelf Reportbusinessmedicine.drugLichen Planus Oral
researchProduct

Optical quality of hyperopic and myopic phakic intraocular lenses

2013

Aims: To assess and compare the optical quality of the myopic and hyperopic implantable collamer lens (ICL) from its wavefront aberrations for different powers and pupil diameters. Settings and Design: Prospective study. Material and Methods: The wavefront aberrations of two myopic (−3 and −6 diopters (D)) and two hyperopic V4b ICLs (+3 and +6D) were measured in vitro . To assess and compare the optical quality of different powers of ICLs, we analyzed the root mean square (RMS) of total higher order aberrations (HOAs), trefoil, coma, tetrafoil, secondary astigmatism, and spherical aberration at 3- and 4.5-mm pupil. In addition, the point spread functions (PSFs) of each ICL evaluated were ca…

steep corneal curvatureintravitreallacrimal fossaRefractive errorvisual acuitygenetic structurespterygium surgerystandard automated perimetryComa (optics)BlindnessPhakic intraocular lenslaw.inventionsubconjunctival bevacizumab injectionCorneaLens Implantation Intraocularlcsh:Ophthalmologylawmodified deep anterior lamellar keratoplastyMitomycin CMaterials TestingAutogenous tissue graftingProspective StudiesDioptreoptical qualityshort wave automated perimetryexcimer lasernon-proliferative diabetic retinopathyMean deviationin vitroheavy silicone oilBevacizumabLens (optics)Aberrations of the eyeSpherical aberrationHyperopiaAntimicrobial effectOriginal ArticleTriamcinolone acetonidehuman trabecular meshwork cellsPhakic Intraocular Lensesmedicine.medical_specialtyImaging in glaucomadisability evaluationconventional silicone oiltriamcinoloneProsthesis DesignKeratoconusphotorefractive keratectomyOphthalmologygrowth factorsmedicineHumansmyopiamyopic implantable collamer lensshort fluctuationsWavefrontmacular edemaoptical coherence tomographyendophthalmitis agentsbusiness.industrybranch retinal vein occlusionretinal nerve fiber layerpterygium recurrencemedicine.diseaseeye diseasesOphthalmologypediatricwavefront aberrationsquality of lifelcsh:RE1-994bypass surgeryHyperopic implantable collamer lenslacrimal drainage systemsense organsbusinessIndian Journal of Ophthalmology
researchProduct

Laserfotokoagulation und photodynamische Therapie (PDT) zur Behandlung der retinalen angiomatösen Proliferation (RAP) bei feuchter altersabhängiger M…

2008

BACKGROUND: Retinal angiomatous proliferation (RAP) is a subtype of neovascular age-related macular degeneration (AMD) with particularly bad prognosis. Diverse treatment modalities are performed. PATIENTS AND METHODS: This is a retrospective review on the treatment results of 41 consecutive patients from 1 / 2003 to 12 / 2005 with RAP stage 1 - 3 (Yannuzzi classification), who were treated with laser photocoagulation, photodynamic therapy (PDT) and intravitreal injection of triamcinolone acetonide (IVT). Follow-up was 12 months minimally. RESULTS: In RAP stage I complete closure of the vascular lesion in 14 / 22 eyes was achieved by 1.2 ± 0.5 sessions of laser photocoagulation (4 × combined…

medicine.medical_specialtyVisual acuityTriamcinolone acetonideRetinal pigment epitheliumgenetic structuresbusiness.industryRetinalMacular degenerationmedicine.diseaseVerteporfineye diseasesSurgeryLesionOphthalmologychemistry.chemical_compoundmedicine.anatomical_structurechemistryOphthalmologymedicineTearssense organsmedicine.symptombusinessmedicine.drugKlinische Monatsblätter für Augenheilkunde
researchProduct

Fluocinolone acetonide vitreous insert for chronic diabetic macular oedema: a systematic review with meta-analysis of real-world experience

2021

AbstractWe conducted a meta-analysis of real-world studies on the 0.19 mg Fluocinolone Acetonide (FAc) intravitreal implant for chronic diabetic macular oedema (DMO), comparing these findings with the Fluocinolone Acetonide for Diabetic Macular Edema (FAME) study. The primary outcome was mean change of best corrected visual acuity (BCVA) at 24 months. Secondary outcomes were 36-month mean BCVA, mean central macular thickness (CMT) change, rates of eyes receiving supplementary intravitreal therapy, cataract surgery, intraocular pressure (IOP)-lowering drops and glaucoma surgery. Mean differences (MDs) with 95% confidence intervals (CIs) were calculated. Nine real-world studies were included.…

medicine.medical_specialtyIntraocular pressuregenetic structuresSciencemedicine.medical_treatmentAnti-Inflammatory AgentsArticleMacular Edema03 medical and health sciences0302 clinical medicineDiabetes complicationsFluocinolone acetonideOphthalmologymedicineGlaucoma surgeryHumans030212 general & internal medicineGlucocorticoidsIntraocular PressureDrug ImplantsDiabetic RetinopathyMultidisciplinarybusiness.industryQRCataract surgeryRetinal diseaseseye diseasesConfidence intervalFluocinolone AcetonideDiabetic macular oedemaMeta-analysis030221 ophthalmology & optometryMedicinesense organsImplantbusinessmedicine.drugScientific Reports
researchProduct

Preoperative, Intraoperative and Postoperative Corticosteroid Use as an Adjunctive Treatment for Rhegmatogenous Retinal Detachment

2020

The treatment for rhegmatogenous retinal detachment (RRD) is surgery, including pars plana vitrectomy (PPV) and scleral buckling (SB). Despite surgical advances, degeneration of the photoreceptors and post-operative complications, such as proliferative vitreoretinopathy (PVR), often occurs as the result of inflammation, preventing complete visual recovery or causing RRD recurrence. There is increasing evidence that in the presence of RRD, the activation of inflammatory processes occurs and the surgery itself induces an inflammatory response. This comprehensive review focuses on the use of different formulations of corticosteroids (CCS), as an adjunctive treatment to surgery, either PPV or S…

Pars planamedicine.medical_specialtyProliferative vitreoretinopathyTriamcinolone acetonidemedicine.medical_treatmentvitrectomylcsh:MedicineVitrectomydexamethasoneReviewtriamcinolonecorticosteroids03 medical and health sciences0302 clinical medicinefluocinolonecorticosteroids; dexamethasone; fluocinolone; rhegmatogenous retinal detachment; scleral buckling; triamcinolone; vitrectomyPrednisoneMedicineCorticosteroidscleral bucklingSettore MED/30 - Malattie Apparato Visivobusiness.industrylcsh:Rrhegmatogenous retinal detachmentRetinal detachmentGeneral MedicineFluocinolonemedicine.diseaseeye diseasesSurgerymedicine.anatomical_structureAdjunctive treatment030221 ophthalmology & optometrybusiness030217 neurology & neurosurgerymedicine.drug
researchProduct

Intralesional corticosteroid injections in the treatment of central giant cell lesions of the jaws: A meta-analytic study

2013

Objective: The aim of this study was to evaluate the response of treatment of central giant cell lesion to intralesional corticosteroid injections. Study Design: Review of articles indexed in PubMed on the topic between the years 1988 and 2011, and development of a descriptive meta-analysis of the results. Results: Sample of 41 patients primarily treated with intralesional corticosteroid injections was obtained, with a male female ratio of 1:0.95, being 23 aggressive and 18 non-aggressive central giant cell lesions. Triamcinolone acetonide and triamcinolone hexacetonide were the drugs used, and 78.0% cases were considered as good result, 14.6% were considered as moderate response and 7.3% w…

Malemedicine.medical_specialtyTriamcinolone acetonidemedicine.drug_classOdontologíaInjections IntralesionalIntralesional corticosteroidLesionAdrenal Cortex HormonesmedicineHumansGiant Cell TumorsGeneral DentistryTriancinolona AcetonidaOral Medicine and Pathologybusiness.industryGiant Cell TumorsMale femaleReview-ArticleCorticosteroides:CIENCIAS MÉDICAS [UNESCO]Jaw NeoplasmsCiencias de la saludResponse to treatmentSurgeryOtorhinolaryngologyGiant cellUNESCO::CIENCIAS MÉDICASCorticosteroidFemaleSurgerymedicine.symptombusinessmedicine.drugMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Treatment of recurrent aphthous stomatitis. A literature review

2014

Recurrent aphthous stomatitis (RAS) is the most common chronic disease of the oral cavity, affecting 5-25% of the population. The underlying etiology remains unclear, and no curative treatment is available. The present review examines the existing treatments for RAS with the purpose of answering a number of questions: How should these patients be treated in the dental clinic? What topical drugs are available and when should they be used? What systemic drugs are available and when should they be used? A literature search was made of the PubMed, Cochrane and Scopus databases, limited to articles published between 2008-2012, with scientific levels of evidence 1 and 2 (metaanalyses, systematic …

medicine.medical_specialtyPathologyTriamcinolone acetonidePopulationOdontologíaReviewRecurrent aphthous stomatitislaw.inventionRandomized controlled trialPrednisonelawmedicineeducationGeneral Dentistryeducation.field_of_studyOral Medicine and Pathologybusiness.industry:CIENCIAS MÉDICAS [UNESCO]DermatologyCiencias de la saludThalidomideSystematic reviewAmlexanoxUNESCO::CIENCIAS MÉDICASbusinessmedicine.drug
researchProduct

An evaluation of the efficacy of a topical gel with Triester Glycerol Oxide (TGO) in the treatment of minor recurrent aphthous stomatitis in a Turkis…

2017

Background Triester glycerol oxide gel (Protefix® Queisser Pharma, Germany) is a new topical agent that has the property of adherence to the oral mucosa by forming a lipid film which protects against mechanical trauma and may help to reduce oral tissue moisture loss and inflammation. The aim of this clinical trial was to determine the efficacy of a topical TGO gel and to also compare it with triamcinolone acetonide pomade in the treatment of minor recurrent aphthous stomatitis. Material and Methods This study was a randomized, double-blind, placebo-controlled clinical trial and 180 patients with the complaint of minor aphthous ulcers were enrolled in this study. The sociodemographic data an…

MaleTriamcinolone acetonideTurkeyAdministration TopicalTABLETStriamcinolone acetonideminor recurrent aphthous stomatitisDISEASEOintmentsULCERATION0302 clinical medicineRecurrenceOral mucosaYoung adultMiddle Aged:CIENCIAS MÉDICAS [UNESCO]030205 complementary & alternative medicineTreatment Outcomemedicine.anatomical_structureULCERSCohortUNESCO::CIENCIAS MÉDICASTopical therapyFemaleStomatitis Aphthousmedicine.drugAdultmedicine.medical_specialtyAdolescentRecurrent aphthous stomatitisPlaceboDouble blindYoung Adult03 medical and health sciencesDouble-Blind MethodInternal medicinemedicinetriester glycerol oxideMANAGEMENTHumansGlucocorticoidsGeneral DentistryAgedOral Medicine and Pathologybusiness.industryResearch030206 dentistrySurgeryClinical trialOtorhinolaryngologySurgeryLASERbusinessGelsPASTE
researchProduct

The use of triamcinolone combined with surgery in major ear keloid treatment: a personal two stages approach

2015

Background: Keloid is a fibroproliferative disorder characterized by an abnormal deposition of collagen within a wound. Despite an increased understanding of wound healing and collagen metabolism, the exact cause, the clinical behavior, and gold standard of treatment for keloids remain an enigma. There is no one right way of treatment, the results are variable, and the management of ear keloids can be difficult and frustrating both for patients and physicians. Traditional techniques include intralesional steroids, topical applications of silicone, vitamins, and segmental excision by lasers or surgery. The purposes of this article are to review the literature concerning the current therapies…

Reconstructive surgerymedicine.medical_specialtyTriamcinolone acetonidebusiness.industryGold standardEvidence-based medicinemedicine.diseaseDermatologySurgeryEar keloidPlastic surgeryKeloidQuality of lifeTriamcinolone acetonide injectionMedicineSurgeryRadical excisionskin and connective tissue diseasesbusinessWound healingmedicine.drug
researchProduct